The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma

A multimodal approach to treating pancreatic ductal adenocarcinoma (PDAC) is now widely accepted. Improvements in radiological assessment have enabled us to define resectability in detail. Multimodality treatment is essential for patients, especially for those with PDAC in the borderline resectable...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakaguchi, Tatsuma, Satoi, Sohei, Yamamoto, Tomohisa, Yamaki, So, Sekimoto, Mitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098925/
https://www.ncbi.nlm.nih.gov/pubmed/31993761
http://dx.doi.org/10.1007/s00595-020-01963-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098925/
https://www.ncbi.nlm.nih.gov/pubmed/31993761
http://dx.doi.org/10.1007/s00595-020-01963-2

Ejemplares similares